TNYA - Tenaya Therapeutics up 6% following director stock purchase
- Tenaya Therapeutics ( NASDAQ: TNYA ) is up ~6% in after-hours trading on Thursday after a member of the board of directors made a large acquisition of additional shares.
- David Goeddel, managing partner at The Column Group, bought 49,463 shares on Jan. 17 at an average price of $2.49 per share, and another 135,688 shares on Jan. 18 at an average $2.52 per share.
- The shares are directly held by The Column Group, who in total own ~5M shares, according to a SEC filing .
- Read why Seeking Alpha contributor Busted IPO Forum recently called Tenaya ( TNYA ) a hold.
For further details see:
Tenaya Therapeutics up 6% following director stock purchase